Nathaniel Martin was appointed Chair of Biological Chemistry at Leiden University, Netherlands in 2018. His research group works on developing new molecular strategies to address antibiotic resistance. With a firm foundation in bioorganic and medicinal chemistry, the approaches used by the Martin lab include the design and synthesis of new antibiotics as well as developing small molecule inhibitors of different resistance mechanisms. Nathaniel has received a number of grants and awards in support of his research from the European Research Council (ERC) and the Dutch Science Foundation (NWO). To date, he has published 135 research papers and is named inventor on 10 patents. Since 2023, Nathaniel is associate editor for the Journal of Medicinal Chemistry, where he oversees submissions on infectious disease.
Nathaniel Martin was born and raised in Western Canada and obtained his PhD degree from the University of Alberta in 2004. He subsequently performed postdoctoral studies at the University of California Berkeley and in 2007 moved to Utrecht University (The Netherlands) to start his independent career. When not thinking about antibiotics, Nathaniel can most likely be found watching his favorite ice-hockey team.